Ipca Laboratories Ltd. Financials: Quarterly Results
Revenue
2584.36
Cr.
PAT
283.50
Cr.
EBITDA
469.45
Cr.
Ipca Laboratories Ltd. Q2FY26 Financial Metrics
| Indicator | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 2556.50 | 2308.85 | 2246.69 | 2245.37 | 2354.90 |
| Total Income From Operations (Cr.) | 2556.50 | 2308.85 | 2246.69 | 2245.37 | 2354.90 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 469.45 | 349.02 | 354.56 | 384.73 | 367.39 |
| P/L Before Exceptional Items & Tax (Cr.) | 449.84 | 330.51 | 333.05 | 367.92 | 344.83 |
| P/L After Tax from Ordinary Activities (Cr.) | 283.50 | 234.42 | 65.78 | 277.33 | 245.44 |
| Net Profit/Loss For the Period (Cr.) | 283.50 | 234.42 | 65.78 | 277.33 | 245.44 |
| Basic EPS | 12.35 | 9.19 | 2.67 | 9.78 | 9.05 |
FAQs
Ipca Laboratories Ltd. announced its quarterly results for Q2 FY2026 on November 13, 2025.
In Q2 FY2026, Ipca Laboratories Ltd. are as follows:
Revenue: ₹2584.36 crore
Net Profit: ₹283.50 crore.
For Q2 FY2026, Ipca Laboratories Ltd. posted ₹2584.36 crore in revenue and ₹283.50 crore in net profit.
Past quarterly results for Ipca Laboratories Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.